Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the publication of results from the RAGE study of ...
PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...
ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
PHOENIX, Feb. 9, 2024 — Injection of a substance to block an artery feeding the dura (protective sack around the brain) along with surgery to remove pooled blood reduced the risk that patients will ...
Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the publication of results from the RAGE¹ (Ruptured Aneurysms Treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results